Domestic COS-accredited firms eye European drug market

Pharmaceutical industry sources say that there is an increasing trend in the number of accreditation of Certification of Suitability of Monographs of the European Pharmacopoeia (COS), being equal to the certification of US FDA. Thus, it is likely that more brisk export drive of the domestic pharmaceutical firms may get the momentum in the European market with better recognition of the domestic ...